AKKARAJU SRINIVAS Insider Trading Activity (ALMS)

Summary

Updated Jul 16, 2026

AKKARAJU SRINIVAS has filed 5 SEC Form 4 filings across 4 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $54.69M. Lifetime open-market sales: $34.39M. Historical track record: 1/5 stars across 18 tracked purchases.

Profile

Srinivas Akkaraju is a corporate executive and director involved in several biopharmaceutical companies, including Scholar Rock Holding Corp and Mineralys Therapeutics, Inc. He has held various roles in the industry, focusing on innovative medicine development.

Role	Insider
Notability	30/100

Board memberships

Scholar Rock Holding Corp
Mineralys Therapeutics, Inc.
Kalaris Therapeutics, Inc.
vTv Therapeutics Inc.
Alumis Inc.

Awards & honors

Director at multiple biopharmaceutical companies
Involvement in innovative medicine development
Experience in corporate governance

Track Record

InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.

InsiderAlpha rating	★☆☆☆☆ (1/5)
Total purchases tracked	18
Purchases with forward-return data	18
30-day win rate	2778%
90-day win rate	7778%
Avg 5-day return	+752.70%
Avg 30-day return	-1308.57%
Avg 90-day return	+4898.44%
Best 30-day return	+3353.78%

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-07-02	ALMS	ALUMIS INC.	A — Grant or award	3.6K	$0.00
2026-06-08	SRRK	Scholar Rock Holding Corp	A — Grant or award	6.8K	$0.00
2026-05-22	KLRS	Kalaris Therapeutics, Inc.	J — Other acquisition / disposition	4.5K	$0.00
2026-05-22	KLRS	Kalaris Therapeutics, Inc.	J — Other acquisition / disposition	14.9K	$0.00
2026-05-22	KLRS	Kalaris Therapeutics, Inc.	J — Other acquisition / disposition	66.9K	$0.00
2026-05-22	KLRS	Kalaris Therapeutics, Inc.	P — Open-market purchase	244.3K	$4.83	$1.18M
2026-02-21	MLYS	Mineralys Therapeutics, Inc.	A — Grant or award	6.2K	$0.00
2026-02-18	KLRS	Kalaris Therapeutics, Inc.	P — Open-market purchase	479.8K	$10.42	$5.00M
2026-01-13	ALMS	ALUMIS INC.	P — Open-market purchase	588.2K	$17.00	$10.00M
2025-12-16	SRRK	Scholar Rock Holding Corp	J — Other acquisition / disposition	1.06M	$7.35	$7.83M
2025-12-16	SRRK	Scholar Rock Holding Corp	P — Open-market purchase	4.4K	$40.97	$180K
2025-12-16	SRRK	Scholar Rock Holding Corp	P — Open-market purchase	12.4K	$40.18	$498K
2025-12-16	SRRK	Scholar Rock Holding Corp	P — Open-market purchase	12.8K	$39.31	$503K
2025-12-04	ALMS	ALUMIS INC.	P — Open-market purchase	66.0K	$8.18	$540K
2025-12-04	ALMS	ALUMIS INC.	P — Open-market purchase	100.0K	$7.75	$775K
2025-12-04	ALMS	ALUMIS INC.	P — Open-market purchase	96.0K	$7.55	$725K
2025-10-03	SRRK	Scholar Rock Holding Corp	P — Open-market purchase	13.7K	$39.52	$543K
2025-10-03	SRRK	Scholar Rock Holding Corp	P — Open-market purchase	80.9K	$38.68	$3.13M
2025-10-03	SRRK	Scholar Rock Holding Corp	P — Open-market purchase	18.4K	$37.89	$698K
2025-10-03	SRRK	Scholar Rock Holding Corp	P — Open-market purchase	319.7K	$37.42	$11.96M

Frequently Asked Questions

Who is AKKARAJU SRINIVAS?

How many SEC Form 4 filings has AKKARAJU SRINIVAS submitted recently?

5 primary Form 4 filings in the last 90 days, covering 4 companies.

Has AKKARAJU SRINIVAS been buying or selling stock?

Recorded transactions: 19 open-market purchases ($54.69M) and 3 open-market sales ($34.39M) across all tracked filings.

How accurate is AKKARAJU SRINIVAS's historical track record?

Across 18 tracked purchases, AKKARAJU SRINIVAS averaged -1308.6% avg 30-day return with a 2778% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.

Where can I see all of AKKARAJU SRINIVAS's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

AKKARAJU SRINIVAS — SEC Form 4 Insider Trading Activity